David A. Drubin

1.5k total citations
18 papers, 969 citations indexed

About

David A. Drubin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, David A. Drubin has authored 18 papers receiving a total of 969 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in David A. Drubin's work include Genomics and Chromatin Dynamics (4 papers), Gene Regulatory Network Analysis (3 papers) and Nuclear Structure and Function (3 papers). David A. Drubin is often cited by papers focused on Genomics and Chromatin Dynamics (4 papers), Gene Regulatory Network Analysis (3 papers) and Nuclear Structure and Function (3 papers). David A. Drubin collaborates with scholars based in United States and Switzerland. David A. Drubin's co-authors include Pamela A. Silver, Jeffrey C. Way, Christopher R. Brown, Oliver J. Rando, Jason M. Casolari, Julian A. Eskin, Elaine P.S. Gee, Caroline M. Ajo‐Franklin, Dirk Landgraf and Dana Pe’er and has published in prestigious journals such as Genes & Development, PLoS Genetics and Cancer Letters.

In The Last Decade

David A. Drubin

17 papers receiving 936 citations

Peers

David A. Drubin

GENET

CTM

Srikant Verma India

Britta Velten Germany

Damien Arnol United Kingdom

Yuexu Jiang United States

Ranjit Randhawa United States

Armando R. Irizarry United States

Dan Tenenbaum United States

Jonathan L. Robinson United States

Olivier Périn France

Sikander Hayat Germany

Srikant Verma India

David A. Drubin

595 ×0.7

105 ×0.7

GENET

54 ×0.8

CTM

34 ×0.6

129 ×2.4

Citations per year, relative to David A. Drubin David A. Drubin (= 1×) peers Srikant Verma

Countries citing papers authored by David A. Drubin

Since Specialization

Citations

This map shows the geographic impact of David A. Drubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Drubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Drubin more than expected).

Fields of papers citing papers by David A. Drubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Drubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Drubin. The network helps show where David A. Drubin may publish in the future.

Co-authorship network of co-authors of David A. Drubin

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Drubin. A scholar is included among the top collaborators of David A. Drubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Drubin. David A. Drubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Campbell, Carly, David A. Drubin, Timothy M. Thomson, et al.. (2017). Mechanisms of Pinometostat (EPZ-5676) Treatment–Emergent Resistance in MLL -Rearranged Leukemia. Molecular Cancer Therapeutics. 16(8). 1669–1679. 46 indexed citations

Thomson, Ty M., Reynald Lescarbeau, David A. Drubin, et al.. (2015). Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis. BMC Medical Genomics. 8(1). 26–26. 29 indexed citations

Daigle, Scott R., Alice McDonald, Timothy M. Thomson, et al.. (2015). Abstract C12: Identification of biomarkers and pathways associated with response to the DOT1L inhibitor Pinometostat (EPZ-5676) in MLL-r leukemia. Molecular Cancer Therapeutics. 14(12_Supplement_2). C12–C12. 1 indexed citations

Martin, Florian, Ty M. Thomson, Alain Sewer, et al.. (2012). Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks. BMC Systems Biology. 6(1). 54–54. 76 indexed citations

Macoritto, Michael, et al.. (2012). A Novel Mechanistic Biomarker Panel Predicts Response to Infliximab in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 18. S61–S61. 2 indexed citations

Laifenfeld, Daphna, David A. Drubin, Natalie L. Catlett, et al.. (2011). Early Patient Stratification and Predictive Biomarkers in Drug Discovery and Development. Advances in experimental medicine and biology. 736. 645–653. 16 indexed citations

Schlage, Walter K., Jurjen W. Westra, Stephan Gebel, et al.. (2011). A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue. BMC Systems Biology. 5(1). 168–168. 51 indexed citations

Hoeng, Julia, Renée Deehan, Dexter Pratt, et al.. (2011). A network-based approach to quantifying the impact of biologically active substances. Drug Discovery Today. 17(9-10). 413–418. 64 indexed citations

Laifenfeld, Daphna, Annalyn Gilchrist, David A. Drubin, et al.. (2009). The Role of Hypoxia in 2-Butoxyethanol–Induced Hemangiosarcoma. Toxicological Sciences. 113(1). 254–266. 32 indexed citations

10.

Lee, Su‐In, Aimée M. Dudley, David A. Drubin, et al.. (2009). Learning a Prior on Regulatory Potential from eQTL Data. PLoS Genetics. 5(1). e1000358–e1000358. 152 indexed citations

11.

Ajo‐Franklin, Caroline M., David A. Drubin, Julian A. Eskin, et al.. (2007). Rational design of memory in eukaryotic cells. Genes & Development. 21(18). 2271–2276. 183 indexed citations

12.

Drubin, David A., Jeffrey C. Way, & Pamela A. Silver. (2007). Designing biological systems. Genes & Development. 21(3). 242–254. 104 indexed citations

13.

Drubin, David A., Arman Garakani, & Pamela A. Silver. (2006). Motion as a phenotype: the use of live-cell imaging and machine visual screening to characterize transcription-dependent chromosome dynamics. BMC Cell Biology. 7(1). 19–19. 32 indexed citations

14.

Dhamne, Chetan, et al.. (2006). The chloromethylketone protease inhibitor AAPF_CMK also targets ATP‐dependent helicases and SAP‐domain proteins. Journal of Cellular Biochemistry. 100(3). 716–726. 4 indexed citations

15.

Drubin, David A., Margaret E. McLaughlin-Drubin, Gary A. Clawson, & Craig Meyers. (2006). A Protease Inhibitor Specifically Inhibits Growth of HPV-Infected Keratinocytes. Molecular Therapy. 13(6). 1142–1148. 7 indexed citations

16.

Drubin, David A., J. Stanley Smith, Wenlei Liu, et al.. (2005). Comparison of cryopreservation and standard needle biopsy for gene expression profiling of human breast cancer specimens. Breast Cancer Research and Treatment. 90(1). 93–96. 8 indexed citations

17.

Casolari, Jason M., Christopher R. Brown, David A. Drubin, Oliver J. Rando, & Pamela A. Silver. (2005). Developmentally induced changes in transcriptional program alter spatial organization across chromosomes. Genes & Development. 19(10). 1188–1198. 154 indexed citations

18.

Drubin, David A. & Gary A. Clawson. (2004). Spontaneous transformation of an immortalized hepatocyte cell line: potential role of a nuclear protease. Cancer Letters. 213(1). 39–48. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact